Because BCL6 plays a dominant role in T cell and B cell responses, the effect of FX1 treatment on Lyme arthritis severity was evaluated in B6 Rag1-/- mice to determine the contribution of T cells and B cells to IFNβ production and arthritis (Fig 9G, 9H and 9J). This evidence concerns the gene BCL6 and arthritic joint disease.